Takeda Pharmaceutical

Pharma / Pharmaceuticals, Healthcare

🚀 Founded 1781 🌎 Japan 🏷️ TAK JP3463000004 ⭐ 500 DCF 65.78⚠️ 💰17.88

ℹ️ Info

🧾 At a Glance 📎 Core Facts 🛍️ Products/Services ⭐ Ratings 🧑‍💼 Executives 💬 My Comments

💡 Analytics

🔔 Insights (2) 🏢 Company Q&A (574) 🛠️ Industry Q&A (121) 🏁 Competitors 📊 Price Low 📈 Price Swings ⚡ SWOT 🏛️ PEST 🌀 Porter's Five Forces ✨ Score Positive ⚠️ Risk Assessment 🧩 Segmentation 🅶 Google Links

💸 Financials

🔄 Cash Flow ⚖️ Balance Sheet 💵 Income Statement 👑 Owner Earnings

📊 Ratios

💰 Margins 📐 Financial Ratios 🌱 Growth 📏 Enterprise Value 📌 Key Metrics 💵 Dividends

🔧 Tools

✅ Due Diligence

📚 Resources

📰 News 🔶 Clusters 🗂️ SEC Filings 🔢 Stock Split History 📢 Press Releases 👤 Insider Trades 📅 Earnings Calendar 🌐 Web 📝 Reports

👤 Insider Trades

[ Disclaimer ]

Date	Type	Name	A/D	Amount	Price	Security
2028-06-01		Reed Kimberly A. director		1180		Tax Obligation Award
2028-06-01		Orsinger Michel Bruno director		1180		Tax Obligation Award
2028-06-01		Furuta Milano director, officer: Chief Financial Officer		4194		Tax Obligation Award
2028-06-01		Weber Christophe Pierre director, officer: President and CEO		17296		Tax Obligation Award
2028-06-01	*****	*****	*****	*****	*****	*****
2028-06-01	*****	*****	*****	*****	*****	*****
2028-01-01	*****	*****	*****	*****	*****	*****
2026-03-18	*****	*****	*****	*****	*****	*****
2026-03-18	*****	*****	*****	*****	*****	*****

🏛️ Explore more insider trade data for Takeda Pharmaceutical!

🎁 Free download! "The Checklist Value Investor — A Smarter Way to Pick Stocks"

What is special about us?

Newsletter

Imprint

Disclaimer

×
Disclaimer

InsightfulValue is an independent platform dedicated to value investing research. The information provided on this website is for informational and educational purposes only and does not constitute financial, investment, tax, or legal advice.
We are not financial advisors, investment consultants, or licensed consultants. Our analyses, insights, and criteria are based on principles learned from renowned value investors such as Benjamin Graham, Warren Buffett, and Charlie Munger, but they should not be considered personalized investment recommendations.
Investing in financial markets carries risks, and past performance is not indicative of future results. Users of this website should conduct their own due diligence and consult with a qualified professional before making any financial or investment decisions. InsightfulValue assumes no liability for any financial losses or decisions made based on the information provided on this site.
By using this website, you acknowledge and accept that all investments involve risk and that InsightfulValue does not guarantee any financial outcomes.

Legal

Due Diligence

To start evaluating the companies of your choice, sign up or log in.